Aarey Drugs & Pharmaceuticals: Revised Outcome of Board Meeting dated 06-08-2026 approved in Board Meeting 30-09-2026
Aarey Drugs & Pharmaceuticals (AAREYDRUGS) filed a disclosure titled "Revised Outcome of Board Meeting dated 06-08-2026 approved in Board Meeting 30-09-2026". The company is valued at about ₹313 crore.
What happened
Aarey Drugs & Pharmaceuticals (AAREYDRUGS) filed a disclosure with the exchanges on 30 September 2026 at 03:06 PM titled "Revised Outcome of Board Meeting dated 06-08-2026 approved in Board Meeting 30-09-2026".
Company snapshot
Aarey Drugs & Pharmaceuticals is a micro-cap company, with a market value of about ₹313 crore.
The stock last traded at ₹101.3, against a 52-week range of ₹50.31–₹104 (2.6% below the high).
Before this filing the shares had moved +12.3% over the month and +13.1% over three months. Average daily turnover over the last 20 sessions was about ₹2.38 crore.
Promoters held 42.79% at the end of Q2 FY27, up 5.08% points from the previous quarter. Foreign institutions owned 4.41% and domestic institutions 1.49%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 102 | 1.4 | 0.48 |
| Q2 FY26 | 84 | 1 | 0.72 |
| Q3 FY26 | 96 | 1.3 | 0.2 |
| Q4 FY26 | 189 | 1.6 | 0.55 |
| Q1 FY27 | 45 | 1 | 0.36 |
What history shows
BCEIE's records show 4 previous board meeting filings from the company since May 2026.
After those filings, the stock fell 1.8% on average the next trading day and was down 0.7% on average after five days (3 filings with price data).
Market-wide, 2,834 board meeting filings with an impact score of 50 or more saw an average next-day move of −0.1%, with 43% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 5 Sept 2026 | Outcome of Board Meeting held on September 05, 2026. | +2.3% | +3.2% |
| 30 May 2026 | Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday,… | −3.1% | +2.5% |
| 25 May 2026 | Board Meeting Intimation for Approving The Audited Financial Results… | −4.8% | −7.6% |
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.